According to the Titan Media App on July 11, WuXi PharmaTech announced that it is expected to achieve a net profit attributable to the parent company of about 4.636 billion yuan in the first half of 2022, a year-on-year increase of about 73.29%; and an operating income of about 17.756 billion yuan, a year-on-year increase of about 68.52%. The company continues to strengthen WuXi AppTec 's unique integrated CRDMO (contract research, development, and production) and CTDMO (contract testing, research and development, and production) business models, formulate and efficiently implement business continuity plans in a timely manner, and ensure the achievement of the company's overall performance goals. Xiaocai Note: The Q1 net profit was 1.643 billion yuan. Based on this calculation, the Q2 net profit is expected to be 2.993 billion yuan, an increase of 82.17% month-on-month.
media coverage
Titanium Media Titanium Media
Related events
- Brother Technology: Pre-profit of 210 million to 270 million yuan in the first half of the year, a year-on-year turnaround 2022-07-11
- TCL Huaxing released the world’s first 0.016Hz ultra-low frequency OLED wearable device screen2022-06-20
- Fogcore Technology’s 2021 annual net revenue is 8.52 billion yuan, a year-on-year increase of 123.1% 2022-03-12
- Hengxuan Technology’s performance report: Net profit in 2021 will increase by 105% year -on-year 2022-02-22
- The volume and price of display panels have increased, and TCL Technology made more than 10 billion last year2022-01-27
This article is reprinted from: https://readhub.cn/topic/8hz1T8Y0d6l
This site is for inclusion only, and the copyright belongs to the original author.